Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 12, Special Issue 8 (2023)

A review: Role of niacin as antihyperlipidemic drug

Author(s):
Dr. Pallavi Khajuria, Dr. Gurpreet Singh, Dr. Dawoud Aamir Nehru, Dr. Inder Pal Singh, Dr. Amit Challana and Dr. Anavil Bhardwaj
Abstract:
Niacin is frequently referred to as a ‘broad spectrum anti-hyperlipidemic drug’. Niacin has been reported to reduce total plasma cholesterol, triglyceride, VLDL, and LDL concentrations and increases HDL concentration. This makes niacin ideal for treating a wide variety of lipid disorders, including the metabolic syndrome, diabetes mellitus, isolated low high-density lipoprotein cholesterol, and hypertriglyceridemia.
Pages: 106-108  |  331 Views  186 Downloads
How to cite this article:
Dr. Pallavi Khajuria, Dr. Gurpreet Singh, Dr. Dawoud Aamir Nehru, Dr. Inder Pal Singh, Dr. Amit Challana and Dr. Anavil Bhardwaj. A review: Role of niacin as antihyperlipidemic drug. The Pharma Innovation Journal. 2023; 12(8S): 106-108.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal


Call for book chapter